Morgan Stanley
GRNAW

Morgan Stanley’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Morgan Stanley’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,206
Closed -$16 – 7827
2023
Q2 		$16 Hold
1,206
– – ﹤0.01% 7593
2023
Q1 		$62 Hold
1,206
– – ﹤0.01% 7599
2022
Q4 		$102 Hold
1,206
– – ﹤0.01% 7695
2022
Q3 		$0 Hold
1,206
– – ﹤0.01% 8019
2022
Q2 		$0 Buy
1,206
+275
+30% +$222 ﹤0.01% 8120
2022
Q1 		$1K Buy
+931
New +$681 ﹤0.01% 7905

Morgan Stanley's GRNAW Position: Q3 2023 in Review

Morgan Stanley sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 1,206 shares — an estimated $16 sold.

Morgan Stanley first reported a position in GRNAW in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

  • Morgan Stanley reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 1,206 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $16.
  • Morgan Stanley first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2022 and held it in 6 quarters.
  • Morgan Stanley's GreenLight Biosciences Holdings, PBC Warrant position peaked at $1K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.